Industry Trends

June 2020

See what has been happening in Asia’s pharma and personal care industries over the last weeks. What are experts and industry magazines talking about?

What has been happening?

Daily Coffee May Lower Risk for Developing Arrhythmia, scientists discover essential protein for healthy skin barrier, metformin Recalled Due to Potential Cancer-Causing Chemical, and more. Find out what journals and industry experts have been discussing in the last four weeks.

Latest Industry Articles

Daily Coffee May Lower Risk for Developing Arrhythmia
Drugs.com

Regular coffee consumption is associated with a significantly lower risk for arrhythmias, according to a study presented recently as part of the Heart Rhythm Society online meeting: HRS 2020 Science.
Read Full Article
Scientists discover essential protein for healthy skin barrier
Cosmetics Business

The research could lead to treating common skin conditions like eczema, psoriasis and dehydration.
Read Full Article
Metformin Recalled Due to Potential Cancer-Causing Chemical
Drugs.com

A recall of the widely used diabetes drug metformin was announced by drug maker Apotex due to possible high levels of N-Nitrosodimethylamine (NDMA), which is believed to cause cancer in people.
Read Full Article
Continuous Glucose Monitoring Aids Glycemic Control in Young
Drugs.com

Continuous glucose monitoring (CGM) improves glycemic control in adolescents and young adults with type 1 diabetes and is beneficial for hypoglycemia in older adults with type 1 diabetes, according to two studies published in the June 16 issue of the Journal of the American Medical Association.
Read Full Article
Blood Pressure Treatment Even Effective in Frail Older Adults
Drugs.com

Even in very frail people, antihypertensive treatment reduces the risk for death, according to a study published online June 8 in Hypertension.
Read Full Article
FDA Sounds An Alarm About 9 Potentially Toxic Hand Sanitizers
Forbes

Hand sanitizer products pose a potential toxic risk if they contain methanol (wood alcohol).
Read Full Article
COVID-19 Mortality Higher for Those Not Taking Meds for Their Hypertension
Drugs.com

COVID-19 patients with hypertension have increased mortality risk, with significantly higher risk among those without antihypertensive treatment, according to a study published online June 4 in the European Heart Journal.
Read Full Article
High Prevalence of Primary Aldosteronism Observed
Drugs.com

Primary aldosteronism is prevalent and increases in parallel with hypertension severity, according to a study published online May 26 in the Annals of Internal Medicine.
Read Full Article
NIH Stops Hydroxychloroquine Trial
Drugs.com

The National Institutes of Health announced Saturday that a clinical trial evaluating hydroxychloroquine for the treatment of COVID-19 has been stopped because the drug likely provides no benefit.
Read Full Article
Feinstein Institutes for Medical Research Finds Extended Drug Treatment Reduces Blood Clots in Discharged Patients, a Side-effect of Recovering COVID-19 Patients
Business Wire

Post-hospitalized patients, especially recently discharged coronavirus disease 2019 (COVID-19) patients, are at higher risk for major thromboembolic events or the formation of blood clots that could lead to death. New research published today in the Journal of the American College of Cardiology shows promise in the extended use of the drug rivaroxaban, a direct oral anticoagulant (DOAC), to prevent those adverse events.
Read Full Article
Cardioprotective Therapy Use Lower With Cancer History
Drugs.com

Cardioprotective therapies, especially statins and antiplatelets, are underutilized in patients with a history of cancer (CaHx), according to a research letter published in the June 1 issue of JACC: CardioOncology.
Read Full Article
Reduced Circadian Rhythmicity Tied to Increase in Parkinson Disease
Drugs.com

Reduced circadian rhythmicity is associated with an increased risk for incident Parkinson disease (PD), according to a study published online June 15 in JAMA Neurology.
Read Full Article

Related Articles & Trends

Pharma & Personal Care Trends – November 2024

Pharma & Personal Care Trends – November 2024

Nov 18, 2024

Beauty 4.0: The state of the menopausal beauty market, New skin care line to address interest in Traditional Chinese Medicine and well-being surges, Benefits of transitioning to E-Cigarettes, and more. See what industry experts have been discussing in the last four weeks.

Pharma & Personal Care Trends – October 2024

Pharma & Personal Care Trends – October 2024

Oct 18, 2024

Sustainable cosmetic packaging innovations at Luxe Pack 2024, One or two-dose HPV vaccination, 3 ways to maintain glowy skin, and more. See what industry experts have been discussing in the last four weeks.

Pharma & Personal Care Trends – September 2024

Pharma & Personal Care Trends – September 2024

Sep 12, 2024

Rutin emerges as a sustainable alternative in sunscreen formulations, Infusing sustainability and transparency into skin care, Formulating menopausal skin care, and more. See what industry experts have been discussing in the last four weeks.

Industry News . Once a month . No spam

Pharmaceuticals

Company

Industries

    Contact Us

    ingredients@jjsea.com

    +66 2787 8787

    Jebsen & Jessen Logo white

    Follow Us